Subretinal Drusenoid Deposits in a Patient With HELLP (Hemolysis, Elevated Liver Enzymes, Low Platelet) Syndrome
Ceren Durmaz Engin1, Omer Karti2, Kutlay Kandemir1
1Department of Ophthalmology, Buca Seyfi Demirsoy Education and Research Hospital, Izmir, TUR.
Subretinal drusenoid deposits (SDD) can indicate poor prognosis in ocular diseases. This case report details SDD occurrence in a patient with HELLP syndrome-induced hypertensive retinochoroidopathy.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Vascular Biology
Background:
- Subretinal drusenoid deposits (SDD) are associated with age-related macular degeneration and ischemic ocular conditions.
- SDD are considered prognostically significant, linked to choroidal neovascularization.
- HELLP (hemolysis, elevated liver enzymes, low platelet) syndrome, a severe preeclampsia complication, can cause ocular issues like hypertensive retinopathy.
Observation:
- This case report focuses on a female patient presenting with hypertensive retinochoroidopathy.
- The condition was secondary to HELLP syndrome.
- The presence and progression of SDD were monitored in this patient.
Findings:
- The patient exhibited subretinal drusenoid deposits.
- The SDD were observed in the context of hypertensive retinochoroidopathy attributed to HELLP syndrome.
- The course and clinical significance of SDD in this specific scenario were documented.
Implications:
- This case highlights a potential association between SDD and hypertensive retinochoroidopathy in HELLP syndrome.
- Understanding SDD in this context may improve prognostic accuracy for ocular complications of HELLP syndrome.
- Further research could explore the role of SDD in predicting outcomes for patients with severe hypertensive crises.
More Related Videos
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
06:16Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
Related Concept Videos
Lysosomal Hydrolases
Nephrotic Syndrome I : Introduction
Diabetic Retinopathy
Portal Hypertension
Hepatic Encephalopathy
